These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27370)

  • 1. Effect of penbutolol (Hoe 893 d) and practolol on exercise-induced angina pectoris 2 and 24 hours after a signle oral dose.
    Westheim AS; Christensen CC; Kjekshus J
    Eur J Clin Pharmacol; 1978 May; 13(3):157-62. PubMed ID: 27370
    [No Abstract]   [Full Text] [Related]  

  • 2. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
    Prahl P; Prahl M
    Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative potency of intravenous penbutolol and propranolol in man.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):83-5. PubMed ID: 24597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-effect relationship and safety of oral administration of penbutolol. A new beta adrenoceptor antagonist in normal subjects.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):98-101. PubMed ID: 25846
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
    Libretti A; Gregorini L; Valentini R
    Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.
    Jackson G; Atkinson L; Oram S
    Br Med J; 1975 Mar; 1(5960):708-12. PubMed ID: 804952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.
    Hansson BG; Hökfelt B
    Eur J Clin Pharmacol; 1975 Oct; 9(1):9-19. PubMed ID: 9298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenergic receptor blocking drugs in angina pectoris.
    Prichard BN
    Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
    Thadani U; Davidson C; Singleton W; Taylor SH
    N Engl J Med; 1979 Apr; 300(14):750-5. PubMed ID: 581782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.
    Aström H; Vallin H
    Br Heart J; 1974 Dec; 36(12):1194-1200. PubMed ID: 4155316
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
    Thadani U; Davidson C; Singleton W; Taylor SH
    Am J Med; 1980 Feb; 68(2):243-50. PubMed ID: 6101934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of practolol on exercise tolerance and cardiac haemodynamics and metabolism in patients with coronary artery disease.
    Dagenais GR; Moisan A; Marquis Y; Davies RO; Blouin S
    Cardiovasc Res; 1976 Jan; 10(1):25-36. PubMed ID: 1253193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind trial of penbutolol: a new beta-receptor blocking agent in the treatment of angina pectoris.
    Agarwal AK; Ahuja RC; Chandra M; Gupta NN; Hasan M
    J Int Med Res; 1976; 4(6):410-7. PubMed ID: 17557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of two doses of bisoprolol on exercise tolerance in exercise-induced stable angina pectoris.
    de Muinck E; Wagner G; vd Ven LL; Lie KI
    Eur Heart J; 1987 Dec; 8 Suppl M():31-5. PubMed ID: 2897300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of LBI45, practolol and a placebo on the exercise tests of coronary patients. A double-blind study (author's transl)].
    Bloch A; Horvat L
    Schweiz Rundsch Med Prax; 1974 Jan; 63(3):62-5. PubMed ID: 4605646
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris.
    Frick MH; Katila M
    Fortn Rev Chic Dent Soc; 1970 Sep; 60(5):96-101. PubMed ID: 4393719
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris.
    Keyriläinen O; Uusitalo A
    Ann Clin Res; 1978 Aug; 10(4):185-90. PubMed ID: 30388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose finding in angina--results with epanolol.
    Omland TM; von Brandis C; Abrahamsen AM
    Drugs; 1989; 38 Suppl 2():35-8. PubMed ID: 2575978
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of the haemodynamic effects in man of the beta-adrenergic blocking substances Kö 1366 and practolol (author's transl)].
    Gloger K
    Arzneimittelforschung; 1975 Aug; 25(8):1300-3. PubMed ID: 241365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect assessment of myocardial oxygen consumption in the evaluation of mechanisms and therapy of angina pectoris.
    Amsterdam EA; Hughes JL; DeMaria AN; Zelis R; Mason DT
    Am J Cardiol; 1974 May; 33(6):737-43. PubMed ID: 4151042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.